Request Trial
1 July 2014

Bingham boosts life sciences practice

Patent counselling specialist Mark Hayman has joined Bingham McCutchen LLP’s Boston office as a partner.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Regulation & Industry
What makes a life sciences deal stack up for buyers?
25 August 2026   While promising science draws in buyers, intellectual property determines the price, terms, and viability of an agreement. LSIPR digs into what buyers are looking for—and the biggest turn-offs that destroy a deal.
Regulation & Industry
UK appoints ex-engineer as new intellectual property Minister
24 August 2026   Labour MP for Stockton North takes up a new role as Minister for Science, Innovation and Investment within Andy Burnham’s government.
Careers
Stris & Maher opens new Dallas office with partner hires
24 August 2026   The four-person team adds significant life sciences experience to the litigation boutique, drawn to move firms by Stris’ “outstanding trial lawyers” and “sophisticated appellate capabilities”.


Editor's picks

Abbott fends off Chinese rival’s patent challenge at UPC
MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026

Editor's picks

MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026
Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026
Regulation & Industry
Why is 2026 already a record year for M&A activity?
17 July 2026
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026
Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026
Biotech
Pfizer’s US Paxlovid patent fight turns on a single error
25 June 2026

More features

What makes a life sciences deal stack up for buyers?
UK appoints ex-engineer as new intellectual property Minister
Stris & Maher opens new Dallas office with partner hires
Teva and Aurinia settle generics dispute over lupus drug, voclosporin
10x Genomics dealt major blow in sequencing fight
SK Biopharmaceuticals settles epilepsy generic dispute
Vanda revives challenge over braille-free label on generic sleep disorder drug
Abbott fends off Chinese rival’s patent challenge at UPC